// App-Quantinova.ai

770 : Negative regulation of the CCL22/CCR4 axis by TNFR1 improves melanoma outcome

Researchers

Presenter

  • Caio Abner Leite

Principal Investigators

  • Paulo Henrique Melo

  • Jose Mauricio Mota

  • Douglas Silva Prado

  • Paula Ramos Viacava

  • Fernando Queiroz Cunha

  • Jose Carlos Alves Filho

Medical Centers

  • A.C. Camargo Cancer Center, Sao Paulo, Brazil

  • University of Sao Paulo, Ribeirao Preto, Brazil

  • University of Sao Paulo, Sao Paulo, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Skin carcinoma

  • Melanoma

  • Solid malignancies

Biomarkers

  • C-C Motif Chemokine Ligand 22

  • C-C Motif Chemokine Receptor 4

  • Cytotoxic T-lymphocyte-associated protein 4

  • TNF Receptor Superfamily Member 1A

  • Tumor necrosis factor

  • Regulatory T cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved